Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 2
2005 2
2006 4
2007 1
2008 4
2009 2
2010 3
2011 4
2012 5
2013 3
2014 3
2015 7
2016 2
2017 2
2018 4
2019 3
2020 5
2021 6
2022 4
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
CSNK2B modulates IRF1 binding to functional DNA elements and promotes basal and agonist-induced antiviral signaling.
Matsumoto M, Modliszewski JL, Shinozaki K, Maezawa R, Perez VM, Ishikawa Y, Suzuki R, McKnight KL, Masaki T, Hirai-Yuki A, Kohara M, Lemon SM, Selitsky SR, Yamane D. Matsumoto M, et al. Among authors: masaki t. Nucleic Acids Res. 2023 May 22;51(9):4451-4466. doi: 10.1093/nar/gkad298. Nucleic Acids Res. 2023. PMID: 37094077 Free PMC article.
Hepatocellular organellar abnormalities following elimination of hepatitis C virus.
Aoyagi H, Iijima H, Gaber ES, Zaitsu T, Matsuda M, Wakae K, Watashi K, Suzuki R, Masaki T, Kahn J, Saito T, El-Kassas M, Shimada N, Kato K, Enomoto M, Hayashi K, Tsubota A, Mimata A, Sakamaki Y, Ichinose S, Muramatsu M, Wake K, Wakita T, Aizaki H. Aoyagi H, et al. Among authors: masaki t. Liver Int. 2023 Aug;43(8):1677-1690. doi: 10.1111/liv.15624. Epub 2023 Jun 13. Liver Int. 2023. PMID: 37312620
Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid.
Qin XY, Furutani Y, Yonezawa K, Shimizu N, Kato-Murayama M, Shirouzu M, Xu Y, Yamano Y, Wada A, Gailhouste L, Shrestha R, Takahashi M, Keillor JW, Su T, Yu W, Fujii S, Kagechika H, Dohmae N, Shirakami Y, Shimizu M, Masaki T, Matsuura T, Suzuki H, Kojima S. Qin XY, et al. Among authors: masaki t. Cell Death Dis. 2023 Jun 13;14(6):358. doi: 10.1038/s41419-023-05847-4. Cell Death Dis. 2023. PMID: 37308486 Free PMC article.
Liver injury and disease pathogenesis in chronic hepatitis C.
Yamane D, McGivern DR, Masaki T, Lemon SM. Yamane D, et al. Among authors: masaki t. Curr Top Microbiol Immunol. 2013;369:263-88. doi: 10.1007/978-3-642-27340-7_11. Curr Top Microbiol Immunol. 2013. PMID: 23463205 Review.
A small molecule iCDM-34 identified by in silico screening suppresses HBV DNA through activation of aryl hydrocarbon receptor.
Furutani Y, Hirano Y, Toguchi M, Higuchi S, Qin XY, Yanaka K, Sato-Shiozaki Y, Takahashi N, Sakai M, Kongpracha P, Suzuki T, Dohmae N, Kukimoto-Niino M, Shirouzu M, Nagamori S, Suzuki H, Kobayashi K, Masaki T, Koyama H, Sekiba K, Otsuka M, Koike K, Kohara M, Kojima S, Kakeya H, Matsuura T. Furutani Y, et al. Among authors: masaki t. Cell Death Discov. 2023 Dec 22;9(1):467. doi: 10.1038/s41420-023-01755-w. Cell Death Discov. 2023. PMID: 38135680 Free PMC article.
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence.
Qin XY, Shirakami Y, Honda M, Yeh SH, Numata K, Lai YY, Li CL, Wei F, Xu Y, Imai K, Takai K, Chuma M, Komatsu N, Furutani Y, Gailhouste L, Aikata H, Chayama K, Enomoto M, Tateishi R, Kawaguchi K, Yamashita T, Kaneko S, Nagaoka K, Tanaka M, Sasaki Y, Tanaka Y, Baba H, Miura K, Ochi S, Masaki T, Kojima S, Matsuura T, Shimizu M, Chen PJ, Moriwaki H, Suzuki H. Qin XY, et al. Among authors: masaki t. Int J Cancer. 2024 Feb 21. doi: 10.1002/ijc.34893. Online ahead of print. Int J Cancer. 2024. PMID: 38380807
69 results